Health Care

Stocks in action: Medtronic plc (NYSE:MDT), Sophiris Bio, Inc. (NASDAQ:SPHS)

0 159

Medtronic plc (NYSE:MDT) closed its last session at $88.36 with the change of +0.99%. The market capitalization of the company is $123.24B with an average Volume of 5.11 million shares. The stock currently has its 52-Week High range of $88.56 and 52-week low range of $55.54. The Price to Book (P/B) ratio stands at 2.35. The stock traded total quantity of 4.4 million shares.

For the current Fiscal Quarter, 23 analysts have given an average earnings per share forecast of $1.02. The Low Earnings per share estimate of the current Quarter is $0.99 and High Estimate is set at $1.08 according to these Analysts opinions. The Previous Year EPS of this Quarter is $1.02.

According to 22 analysts, an average sales Estimate of the current Fiscal quarter is $7.20B. The lower sales estimate is $7.10B and higher sales estimate is $7.33B according to these Analysts thoughts.

The Company currently has Highest Price Target of $98 and Lowest Price Target of $45. It has Median Price Targets of $92. Mean price target is set at $87.07 after consensus analysis of 21 brokers.

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 0 analysts have assigned this stock as Strong Buy where 0 assigned Buy, 5 analysts believe it’s a Hold, 15 said Underperform and 6 assigned Sell rating.

Sophiris Bio, Inc. (NASDAQ:SPHS) ended its last trade at $2.44 with the move of -2.01%. The company has market value of $50.79M with the total traded volume of 1.31 million. The stock currently has its 52-Week top value of $3.85 and 52-week down value of $0.67. . Its previous closing price was recorded at $2.49.

The Company currently has High Price Target of $5. The Low and Mean Price Targets are $4 and $4.5 respectively. These price targets are set after consensus analysis of 2 brokers.

 

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 0 analysts have given this stock as Strong Buy where 0 issued Buy, 0 analysts think that it’s a Hold, 2 told Underperform and0 assigned Sell rating.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter